欢迎访问《岭南现代临床外科》官方网站,今天是

岭南现代临床外科 ›› 2025, Vol. 25 ›› Issue (05): 288-296.DOI: 10.3969/j.issn.1009-976X.2025.05.002

• 论著与临床研究 • 上一篇    下一篇

探究ETV4与结直肠癌的关系

刘锦裕1, 国强2*, 马兴越1, 陈会文1, 徐鸿超1   

  1. 1.内蒙古科技大学包头医学院, 内蒙古包头 014010;
    2.内蒙古科技大学包头医学院第一附属医院, 内蒙古包头 014010
  • 通讯作者: *国强,Email:gq20061282@163.com

Exploring the relationship between ETV4 and colorectal cancer

LIU Jin-yu1, GUO Qiang2*, MA Xing-yue1, CHEN Hui-wen1, XU Hong-chao1   

  1. 1. Baotou Medical College of Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia 014010, China;
    2. The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia 014010, China
  • Received:2025-08-25 Published:2025-11-11
  • Contact: GUO Qiang,gq20061282@163.com

摘要: 目的 探究ETS转录因子4(ETV4)与结直肠癌的关系。方法 收集40例结直肠癌患者的癌组织及癌旁组织,采用RT-qPCR及免疫组化法检测癌组织和癌旁组织中ETV4的表达水平。通过生物信息学方法,使用cBioPortal数据库分析ETV4的突变情况;通过String数据库提取ETV4相关蛋白质相互作用网络;通过UALCAN数据库分析ETV4的表达与结直肠癌分期、淋巴结转移情况、年龄、性别等临床数据之间的关系;通过Kaplan-Meier Plotter数据库分析ETV4的表达与患者预后的关系。结果 RT-qPCR及免疫组化显示,与癌旁组织相比,ETV4在结直肠癌患者癌组织中的表达水平显著升高(P<0.01);cBioPortal数据库显示ETV4在结直肠癌中的突变类型主要包括错义突变和剪切突变;UALCAN数据库分析得出ETV4的表达与结直肠癌的TNM分期、组织学亚型、是否合并TP53突变均有相关性(P<0.05),该基因的表达与患者年龄、性别、种族、体重无相关性(P>0.05);Kaplan-Meier Plotter分析生存曲线显示,与ETV4低表达的结直肠癌患者相比,高表达患者的总生存期(OS)显著延长(Logrank P=0.031,HR=0.8,95%CI:0.66~0.98);肿瘤进展后生存期(PPS)显著改善(Logrank P=0.005,HR=0.64,95%CI:0.47~0.88)。结论 ETV4在结直肠癌组织中表达上调,其高表达与预后良好相关。这表明ETV4有望成为预测患者预后情况的重要指标,同时也为未来临床治疗提供了新的靶点方向。

关键词: 结直肠癌, ETV4, 生物信息学

Abstract: Objective To explore the relationship between ETS transcription factor 4 (ETV4) and colorectal cancer. Methods Colorectalcancer tissues and adjacent tissues from 40 cancer patients were collected. RT-qPCR and immunohistochemistry were used to detect ETV4 expression levels. Bioinformatics methods were applied: cBioPortal for ETV4 mutation analysis, String to extract its protein-protein interaction network, UALCAN to analyze the correlation between ETV4 expression and clinical data like cancer stage, lymph node metastasis, age, and gender, and Kaplan-Meier Plotter to analyze the relationship between ETV4 expression and patient prognosis. Results RT-qPCR and immunohistochemistry showed that ETV4 expression was significantly higher in cancer tissues than in adjacent tissues (P<0.01). cBioPortal showed that ETV4 mutations in colorectal cancer mainly included missense and splice mutations. UALCAN analysis indicated that ETV4 expression was correlated with TNM stage, histological subtype, and TP53 mutation status (P<0.05), but not with age, gender, race, or weight (P>0.05). Kaplan-Meier analysis demonstrated that high ETV4 expression was associated with significantly improved overall survival (OS; Logrank P=0.031, HR=0.8, 95%CI: 0.66~0.98) and post-progression survival (PPS; Logrank P=0.05, HR=0.64, 95%CI: 0.47~0.88) in colorectal cancer patients. Conclusion The upregulation of ETV4 in colorectal cancer tissues correlates with a better prognosis, indicating its potential as a promising prognostic biomarker and a novel therapeutic target.

Key words: colorectal cancer, ETV4, bioinformatics

中图分类号: